INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 AND PROTEIN-3 STIMULATE GROWTH-HORMONE RECEPTOR-BINDING AND MITOGENESIS IN RAT OSTEOSARCOMA CELLS

被引:60
|
作者
SLOOTWEG, MC
OHLSSON, C
SALLES, JP
DEVRIES, CP
NETELENBOS, JC
机构
[1] FREE UNIV AMSTERDAM HOSP,RES INST ENDOCRINOL,1007 MB AMSTERDAM,NETHERLANDS
[2] SAHLGRENS UNIV HOSP,ENDOCRINOL & METAB RES CTR,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.1210/en.136.10.4210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH exerts its biological actions an osteoblasts through a specific high affinity receptor expressed on these cells. GH receptor binding is positively modulated by a number of factors, including retinoic acid and dexamethasone, whereas fetal calf serum strongly decreases the binding. To identify responsible factors in serum, components of serum, the insulin-like growth factors (IGFs)-I and -II, and IGF binding proteins (IGFBPs)-2 and -3 were tested for a possible negative modulatory role. IGF-I and -II decreased [I-125]hGH binding at an optimal concentration of 30 ng/ml for IGF-I and 100 ng/ml IGF-II, reducing the binding to 51% and 55%, respectively, of control values. A stimulation of [I-125]hGH binding was observed with IGFBP-2 as well as IGFBP-3, inducing an increase to 148% and 151% of control binding at an optimal concentration of 3000 ng/ml for both peptides. The effects of all peptides were dependent on the incubation time, being significantly increased after 8 h of incubation and reaching the full effect thereafter. The effects were declined at 24 h compared with 16 h for IGFBP-2 and -3 but not for IGF-I and -II. Coincubation of the cells with TGF-I and -II and IGFBP-2 and -3 neutralized the effects of the factors alone. In conclusion, these results show that IGF-I and -II on the one hand and IGFBP-2 and -3 on the other hand exert opposite actions on [I-125]hGH binding, IGFBP-5 and -3 exerting probably an IGF-independent effect. Further, IGF-I and -II decreased GH receptor messenger RNA (mRNA) levels, as quantified by a solution hybridization ribonuclease protection assay, from 8.65 +/- 1.78 attomoles (amol)/mu g DNA (control) to 2.4 +/- 0.68 and 2.16 +/- 0.92 amol/mu g DNA, respectively. IGFBP-5 increased GH receptor mRNA levels from 5.26 +/- 1.17 (control) to 18.19 +/- 3.48. Incubation with IGFBP-3 did not result in stimulation of GH receptor mRNA levels (8.59 +/- 2.91 amol/mu g DNA). This shows that the mechanism of regulation of the GH receptor is, except for IGFBP-3, at least in part on the mRNA level. Lastly, IGFBP-2 and IGFBP-3 are mitogenic for UMR-106.01 rat osteosarcoma cells, inducing an increase in cell number to 125% and 142% of control cell counts after 48 h of incubation with 1000 ng/ml IGFBP-2 and -3, whereas IGF-I, IGF-II and Long R(3) IGF-I did not stimulate proliferation. IGFBP-2 and -3 potentiate hGH induced mitogenesis at low hGH concentrations of both factors, whereas at higher concentrations no such effect is observed. IGF-I and -II inhibit hGHs action. The physiological relevance of GH receptor modulation is a subject of investigation at the present time.
引用
收藏
页码:4210 / 4217
页数:8
相关论文
共 50 条
  • [1] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 ENHANCES INSULIN-LIKE GROWTH-FACTOR BINDING AND MITOGENESIS IN OSTEOBLAST-LIKE CELLS
    ANDRESS, DL
    LOOP, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S216 - S216
  • [2] CHANGES IN ERYTHROCYTE INSULIN-LIKE GROWTH FACTOR-I RECEPTORS, GROWTH-HORMONE BINDING-PROTEIN, INSULIN-LIKE GROWTH FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3, AND GROWTH-RATE DURING GROWTH-HORMONE TREATMENT
    MANDEL, S
    MORELAND, E
    HANNA, C
    LAFRANCHI, S
    CLINICAL RESEARCH, 1994, 42 (01): : A21 - A21
  • [3] Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3
    Pirazzoli, P
    Cacciari, E
    DeIasio, R
    Pittalis, MC
    Dallacasa, P
    Zucchini, S
    Gualandi, S
    Salardi, S
    David, C
    Boschi, S
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 77 (02): : F100 - F104
  • [4] Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis
    Darren J. Bridgewater
    Douglas G. Matsell
    Pediatric Nephrology, 2003, 18 : 1109 - 1115
  • [5] Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis
    Bridgewater, DJ
    Matsell, DG
    PEDIATRIC NEPHROLOGY, 2003, 18 (11) : 1109 - 1115
  • [6] INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 COMPARED WITH STIMULATED AND OVERNIGHT GROWTH-HORMONE IN SHORT CHILDREN
    ROSE, SR
    NUNEZ, SB
    CLINICAL RESEARCH, 1992, 40 (01): : A25 - A25
  • [7] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 - BIOCHEMISTRY AND PHYSIOLOGY
    MARTIN, JL
    BAXTER, RC
    GROWTH REGULATION, 1992, 2 (02): : 88 - 99
  • [8] Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells
    Slootweg, MC
    Ohlsson, C
    vanElk, EJ
    Netelenbos, JC
    Andress, DL
    GROWTH REGULATION, 1996, 6 (04): : 238 - 246
  • [9] NONPARALLEL CHANGES OF GROWTH-HORMONE (GH) AND INSULIN-LIKE GROWTH FACTOR-I, INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3, AND GH-BINDING PROTEIN, AFTER CRANIOSPINAL IRRADIATION AND CHEMOTHERAPY
    NIVOT, S
    BENELLI, C
    CLOT, JP
    SAUCET, C
    ADAN, L
    SOUBERBIELLE, JC
    ZUCKER, JM
    RAPPAPORT, R
    BRAUNER, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03): : 597 - 601
  • [10] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 CONCENTRATIONS AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 PROTEASE ACTIVITY IN SERA OF PATIENTS WITH MALIGNANT SOLID TUMORS OR LEUKEMIA
    MULLER, HL
    OH, Y
    GARGOSKY, SE
    WILSON, KF
    LEHRNBECHER, T
    ROSENFELD, RG
    PEDIATRIC RESEARCH, 1994, 35 (06) : 720 - 724